Intermittent treatment for TB and resistance

被引:2
作者
Conde, Marcus Barreto [1 ]
机构
[1] Univ Fed Rio de Janeiro, Inst Doencas Torax, Rio De Janeiro, Brazil
关键词
Sleep apnea; obstructive; Sleep disorders; Questionnaires; TUBERCULOSIS; 5-YEAR;
D O I
10.1590/S1806-37132009000600001
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Objective: To determine the prevalence of obstructive sleep apnea syndrome (OSAS), as well as to identify factors associated with a greater risk of developing OSAS, among truck drivers. Methods: The study population comprised 209 truck drivers (mean age, 38.8 years; 98.5% males) at two branches of a transportation company. The mean body mass index was 26.5 +/- 4.4 kg/m(2). The participants completed questionnaires regarding sociodemographic data, physical activity and OSAS. The prevalence of OSAS was estimated using the Berlin Questionnaire, associations between OSAS and the factors studied being assessed through univariate and multivariate regression analysis. Results: The prevalence of OSAS in the population was 11.5%. Of the 209 truck drivers, 72 (34.5%) reported having fallen asleep while driving and 81 (38.7%) reported snoring. The following variables were found to present statistically significant associations with OSAS: informal employment (OR 0.27; p = 0.01); body mass index >= 25 kg/m(2) (OR = 13.64; p = 0.01); and poor sleep quality (OR = 3.00; p = 0.02). Conclusions: The prevalence of OSAS in this study was lower than that reported in other studies of truck drivers and yet higher that that observed for the general population. In addition, our results suggest that work characteristics, such as employment status, are associated with OSAS. These data show the relevance of considering Work activity in studies of factors associated with OSAS.
引用
收藏
页码:497 / 499
页数:3
相关论文
共 10 条
[1]   Prevalence of drug-resistant Mycobacterium tuberculosis in patients under intermittent or daily treatment [J].
Alvarez, Tomas Aiza ;
Rodrigues, Marcelo Palmeira ;
de Assis Viegas, Carlos Alberto .
JORNAL BRASILEIRO DE PNEUMOLOGIA, 2009, 35 (06) :555-560
[2]  
[Anonymous], 1959, B WORLD HEALTH ORGAN
[3]  
CASTELO A, 1989, LANCET, V2, P1173
[4]   Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial [J].
Conde, Marcus B. ;
Efron, Anne ;
Laredo, Carla ;
Muzy De Souza, Gilvan R. ;
Graca, Nadja P. ;
Cezar, Michelle C. ;
Ram, Malathi ;
Chaudhary, Mohammad A. ;
Bishai, William R. ;
Kritski, Afranio L. ;
Chaisson, Richard E. .
LANCET, 2009, 373 (9670) :1183-1189
[5]  
DAWSON JJY, 1966, B WORLD HEALTH ORGAN, V34, P533
[6]  
DEMELO FAF, 2002, B PNEUMOL SANIT, V10, P21
[7]  
KAMAT SR, 1966, B WORLD HEALTH ORGAN, V34, P517
[8]  
Mitchison DA, 1998, INT J TUBERC LUNG D, V2, P10
[9]   LABORATORY ASPECTS OF INTERMITTENT DRUG THERAPY [J].
MITCHISON, DA ;
DICKINSON, JM .
POSTGRADUATE MEDICAL JOURNAL, 1971, 47 (553) :737-+
[10]  
1970, B WHO, V43, P143